At a glance
- Originator Karo Bio
- Class Benzofurans; Carboxylic acids; Class III antiarrhythmics; Iodobenzenes; Small molecules
- Mechanism of Action Thyroid hormone receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 12 Mar 2002 A study has been added to the Arrhythmias pharmacodynamics section
- 12 May 2000 KB 130015 is available for licensing (http://www.karobio.se)
- 03 Jun 1999 Preclinical development for Arrhythmias in Sweden (Unknown route)